Pre-Emptive Initiation of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema Improves Outcomes: A Randomized Controlled Trial.
Aliment Pharmacol TherJun 22, 2026 (epub)
Rakhi Maiwall, Meenu Bajpai, Samba Siva Rao Pasupuleti et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial investigated the effects of early continuous renal replacement therapy (CRRT) initiation in patients with acute liver failure (ALF) and cerebral edema (CE). The study found that pre-emptive CRRT within the first 12 hours significantly reduced the hazard of death during the first 7 days (2.2% vs. 17.8%, HR 0.12) compared to delayed initiation.
Key findings
- Pre-emptive CRRT reduced the hazard of death in the first 7 days (HR 0.12).
- 28-day mortality was higher in the delayed CRRT group (80% vs. 46%, HR 3.10).
- Each hour delay in CRRT was associated with increased mortality (HR 1.01).
- Significant improvements in ammonia levels and mean arterial pressure were observed with early CRRT.
Why it matters
The findings suggest that early initiation of CRRT in ALF patients with CE may improve short-term survival and hemodynamic stability, highlighting the importance of timely intervention in critical care settings.